| |
Overview
HeadlinesNo recent Headlines for this stock. Business Background Allakos Inc is a clinical stage biotechnology company. It develops AK002 monoclonal antibody, for the treatment of various eosinophil and mast cell related diseases.
| |
![]() |
|
| |
Overview
HeadlinesNo recent Headlines for this stock. Business Background Allakos Inc is a clinical stage biotechnology company. It develops AK002 monoclonal antibody, for the treatment of various eosinophil and mast cell related diseases.
| |